What is in this article?:
Taking a pharmaceutical meeting outside the U.S. can get complicated as you have to consider the meeting's host country's rules around payments to healthcare providers, as well as those of the HCPs' home countries. This article offers a country-by-country snapshot of HCP-related rules and codes, and tips on other things to consider when planning a meeting for HCPs outside of the U.S.
Test Your Global Pharma Regs Knowledge
In a Jeopardy-style session that soon got participants popping out of their seats, attendees at the 2012 West Coast Life Sciences Meeting Management Forum had the opportunity to test theirregulatory knowledge.
Session leaders Agnes Canonica, CMP, CMM, general manager, North America and Latin America, MD Events; Michelle Bartolone, CMP, CEO of Meeting Sites Pro, Inc.; Angie Duncan, director, SMM operations, North America, Carlson Wagonlit Travel; and Kimmarie Everett,and event manager, Biolase, lobbed questions that started out fairly easy (e.g., the name of the U.S. law that will require tracking and reporting spend on physicians, which attendees quickly pegged as the Sunshine Act). But they didn’t always throw softballs. Test your international regs knowledge against some of their brain teasers:
1. The document issued by the Office of the Inspector General that outlines the obligations an entity agrees to as part of a civil settlement.
2. Makers of drugs, medical devices, biological, and medical supplies, and group purchasing organizations comprise this group.
3. The government agency that regulates life sciences companies’activities
1. Country with a 60 euro dinner cap (including beverages)
2. HCPs from this country must arrive no earlier than 12 hours prior to the start of the event and depart within 12 hours post event, and must fly coach no matter the destination.
3. The European Union’s equivalent of AdvaMed.
Click here for the answers.